Studying RSV illness impact in babies with ear or lung symptoms
Part of Ear, nose & throat, Infections clinical trials.
This study looks at how RSV (a common virus that can affect breathing) leads to illness in young children who come to the doctor with ear infections and/or breathing symptoms. It may help doctors better understand the “burden” RSV causes in both home/outpatient and hospital settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 24 months old (24 months or younger).
- A parent or legal guardian must sign the consent form.
- Your child must have health coverage under the country’s social security or universal medical coverage.
- The child must have acute purulent ear infection (ear infection with pus) or ear drainage (otorrhea), with or without bronchiolitis (breathing inflammation in babies).
- The child must not be older than 24 months, and the parent must not refuse participation.
- The child’s mother must not have received an RSV vaccine during pregnancy for this study to include them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well RSV vaccines or antibody shots protect babies from severe respiratory infections. If your baby is under 1 year old, lives in Connecticut, and gets sick with a respiratory infection, they may be able to join.
This study tests a new antibody shot (called enflonsia) to help protect babies under 8 months old from RSV, a common virus that can cause breathing problems. If your baby qualifies, they will receive the shot and be followed for about 6 months to see how well it works.
This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.
This study follows babies under 12 months old who are hospitalized with bronchiolitis to understand their treatment and outcomes. It includes tracking RSV testing and a new immunization called nirsevimab, which may help protect against severe illness.
This study looks at how the germs in a baby's gut and their immune system respond to bronchiolitis (a common lung infection). If your baby is under 12 months and gets bronchiolitis during the RSV season, their participation could help us understand why some babies get very sick and others don't.
This study looks at how the bacteria in the gut and the immune system respond in infants hospitalized with severe RSV infection. It may help doctors understand why some babies get sicker and could lead to better treatments.
Hear when a new RSV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.